Redeye: Formpipe - A solid step towards the 2025 margin target
Redeye strengthens its positive view of Formpipe following the Q1 report. Solid ACVs in Q4 2024 and this quarter along with cost cuts, set Formpipe for a year of improving margins.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/